News

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
Discover magnetic bead technology for efficient and reliable viral nucleic acid isolation in clinical applications.
The session titled “Defeating Cancer by Curing Infections” at European Society of Clinical Microbiology and Infectious ...
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.
Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...
Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...
Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...
According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...
From October this year, all newborns will be vaccinated against Hepatitis B Virus (HBV) at birth, the Programme Manager of the Expanded Programme on Immunisation (EPI), Dr Kwame Amponsah-Achiano, has ...
Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...